Moderna’s stock pops after biotech ekes out a surprise profit, and revenue beats by a wide margin
Read more at MarketWatch
Topics
-
Gilead’s third-quarter earnings beat by a wide margin, and biotech raises guidance
Business - MarketWatch - November 7 -
Southwest Airlines beats on revenue by a wide margin, names new board members
Business - MarketWatch - October 24 -
Chevron’s stock climbs after a triple beat of profit, revenue and production
Business - MarketWatch - November 1 -
Toast’s stock soars after company swings to profit and revenue beats estimates
Business - MarketWatch - November 8 -
Planet Fitness’s stock rallies as it beats profit and revenue estimates
Business - MarketWatch - November 7 -
WK Kellogg’s stock soars as strength in granola and premium cereals boosts sales
Business - MarketWatch - November 7
More from MarketWatch
-
Viking Therapeutics is more than just a weight-loss stock, and that’s drawing cheers
Business - MarketWatch - 5 minutes ago -
BJ’s stock surges on first membership fee increase in seven years
Business - MarketWatch - 19 minutes ago -
Starbucks’ China business is struggling. Here’s how the company may give it a jolt.
Business - MarketWatch - 22 minutes ago -
Temu parent’s stock tumbles after a big earnings miss as competition intensified
Business - MarketWatch - 37 minutes ago -
Adani Group companies lose $26 billion in market value after U.S. indictment
Business - MarketWatch - 39 minutes ago